Medical/Pharmaceuticals

Frost & Sullivan Reported The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics

SHANGHAI, May 29, 2024 /PRNewswire/ -- Recently, Frost & Sullivan released the report "The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics".  I.  CDMOs are advancing the biopharmaceutical industry with superior biomanufacturing capabilities...

2024-05-29 14:08 1773

Spectacular advances creating a revolution in the diagnosis and treatment of male infertility

MANILA, Philippines, May 29, 2024 /PRNewswire/ -- Spectacular advances in the diagnosis and treatment of male infertility are offering new hope to the one in six couples globally who seek assisted reproduction to achieve their dreams of parenthood. A major conference on human reproduction in t...

2024-05-29 12:42 1567

US-Based Neurobiotic Leader Bened Life enters Japan market with Neuralli™ MP

FREMONT, Calif., May 29, 2024 /PRNewswire/ -- Bened Life , the leader in psychobiotics, has begun worldwide expansion after finding success inthe United States with Neuralli™ MP - the first gut-brain medical probiotic for neurological conditions. With investment from Teij...

2024-05-29 10:00 2455

SKT Launches AI-powered Veterinary Diagnostic Assistance Service X Caliber in Australia

* In collaboration with ATX Medical Solutions, SKT launches X Caliber in Australia, which has one of the highest rates of pet ownership in the world * SKT also inked a commercial contract with MEDIVET Pet Hospital & Clinic to offer X Caliber inIndonesia. SEOUL, South Korea, May 29, 2024 /PRNew...

2024-05-29 08:32 1482

TREEFROG THERAPEUTICS PICKS-UP BEST POSTER AWARD AT THE INTERNATIONAL SOCIETY FOR CELL & GENE THERAPY (ISCT) ANNUAL MEETING FOR THEIR CELL THERAPY PROGRAM IN PARKINSON'S DISEASE

-  Treefrog will present two posters on their cell therapy program in Parkinson's Disease and their proprietary encapsulation technology, C-Stem™ -   BORDEAUX, France, May 29, 2024 /PRNewswire/ -- TreeFrog Therapeutics  has a busy schedule at the ISCT's 30th annual meeti...

2024-05-29 06:00 1485

GC Cell participates 2024 BIO International Convention, Unveiling its future Blueprint 2.0, as the First Korean Business Forum Sponsor

SAN DIEGO, May 28, 2024 /PRNewswire/ -- GC Cell ,  a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, proudly announces its role as the first Korean Business Forum sponsor at the upcoming 2024 BIO International Convention. Set ...

2024-05-28 23:00 1473

Rege Nephro CO., Ltd. Announces Patient Enrollment for Phase II Clinical Trial of Tamibarotene for ADPKD

KYOTO, Japan, May 28, 2024 /PRNewswire/ -- Rege Nephro CO., Ltd. ( https://www.regenephro.co.jp/en ) has announced that patient enrollment began in April for the second stage of its Phase II clinical trial of tamibarotene as a dev...

2024-05-28 23:00 1903

Metabolon Now Includes Spectral Data Files for All Global Discovery Panel Projects

MORRISVILLE, N.C., May 28, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced the availability of spectral data fil...

2024-05-28 21:00 1380

AUVON Launches a New Professional TENS Unit "AUVON PT1 Pro", Offering a Drug-free Pain Relief Way at Home

Enjoy Convenient, Professional-grade, and Customizable Pain Relief with AUVON 7000 LEWES, Del., May 28, 2024 /PRNewswire/ -- AUVON, a leading expert in the field of professional pain management, has launched AUVON 7000 TENS Unit Muscle Stimulato...

2024-05-28 20:30 1941

From Research to Practice: Prof. Gang Shen and Smartee's Contributions to the ASO Clinical Day 2024

SYDNEY, May 28, 2024 /PRNewswire/ -- Smartee Denti-Technology, a global leader in clear aligners and digital orthodontic solutions, demonstrated its commitment to transforming research into practical clinical applications at the ASO Clinical Day 2024.5.24. ASO is the largest dental specialist so...

2024-05-28 19:19 1364

HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for Eye and Ear Diseases

* Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. * Collaboration aims to leverage HanAll's extensive expertise in ophthalmic and otic diseases and Turn Bio's cellular reprogramming technology to create innova...

2024-05-28 19:00 1474

Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear Therapies

* Synergistic collaboration to revolutionize age-related therapies worldwide * Deal valued at over $300 million USD for initial product MOUNTAIN VIEW, Calif., May 28, 2024 /PRNewswire/ -- Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, today announced an e...

2024-05-28 19:00 1358

Lifespin GmbH and Acıbadem Forge a Groundbreaking Metabolomics Partnership to Advance Personalized Medicine

ISTANBUL and REGENSBURG, Germany, May 28, 2024 /PRNewswire/ -- lifespin GmbH, a pioneer in health status detection software, has teamed up with Acıbadem University (ACU) and Acıbadem Healthcare Group (AHG) to launch a comprehensive precision medicine initiative, a significant stride towards revol...

2024-05-28 14:00 1424

Ovarian tissue transplantation is gaining ground for fertility preservation in young and old, with potential to offset adverse effects of menopause

MANILA, Philippines, May 28, 2024 /PRNewswire/ -- More than 10,000 women and girls around the world facing urgent treatments for cancers and other serious conditions that threatened their fertility have had their motherhood potential preserved by surgical removal and freezing of ovarian tissue. ...

2024-05-28 11:36 1528

Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA to the NMPA

SAN FRANCISCO and SUZHOU, China, May 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2024-05-28 08:00 2580

Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome

Highlights: * Statistically significant improvement from baseline assessed by both clinicians and caregivers in all four efficacy measures specifically designed for Pitt Hopkins syndrome (Wilcoxon signed rank test p<0.05) * Clinician and caregiver global efficacy measures showed a level of i...

2024-05-27 18:00 1917

Driving a consensus approach to improve the lives and fertility health of women stricken with endometriosis

MANILA, Philippines , May 27, 2024 /PRNewswire/ -- Specialists in reproductive health in theAsia Pacific region are advancing a pathfinding initiative to improve the lives of millions of women around the world who suffer from endometriosis. The debilitating condition affects up to 10 per cent ...

2024-05-27 13:00 1925

Chula Medicine Joins Forces with the Department of Thai Traditional and Alternative Medicine to Determine "Curcumin" as Effective Treatment for Dyspepsia as Modern Antacids

Chula  Medicine in collaboration with the Department of Thai Traditional and Alternative Medicine and Gastroenterologists from local medical schools proves thatThai curcumin  can help treat dyspepsia as effectively as ant...

2024-05-27 11:00 2752

Telix Submits NDA for New Prostate Cancer Imaging Agent

MELBOURNE, Australia, May 27, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) tothe United States (U.S.) Food and Drug Administration (FDA) for TLX007-CDx, a new and proprietary cold kit ("Kit") for th...

2024-05-27 07:21 1909

Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response

- Lunit's ASCO 2024 presentations to highlight advances including HER2 ultra-low detection and AI-powered ICI response prediction models for NSCLC, demonstrating the impact of Lunit SCOPE suite on precision oncology SEOUL, South Korea, May 24, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leadin...

2024-05-24 22:07 5477
1 ... 60616263646566 ... 610

Week's Top Stories